Financial Management Professionals’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.2K Sell
18
-11
-38% -$7.49K ﹤0.01% 562
2026
Q1
$22.4K Buy
29
+9
+45% +$6.89K ﹤0.01% 383
2025
Q4
$15.4K Hold
20
﹤0.01% 456
2025
Q3
$11.2K Hold
20
﹤0.01% 506
2025
Q2
$10.5K Sell
20
-14
-41% -$7.81K ﹤0.01% 536
2025
Q1
$21.6K Sell
34
-1
-3% -$688 ﹤0.01% 414
2024
Q4
$24.9K Sell
35
-1
-3% -$839 ﹤0.01% 370
2024
Q3
$38K Hold
36
﹤0.01% 303
2024
Q2
$38K Sell
36
-82
-69% -$79.5K 0.01% 296
2024
Q1
$114K Sell
118
-5
-4% -$4.75K 0.02% 189
2023
Q4
$108K Sell
123
-2
-2% -$1.65K 0.02% 178
2023
Q3
$103K Buy
125
+8
+7% +$6.29K 0.02% 172
2023
Q2
$84K Buy
117
+1
+0.9% +$771 0.01% 208
2023
Q1
$95K Buy
116
+85
+274% +$64.1K 0.02% 210
2022
Q4
$22K Hold
31
﹤0.01% 353
2022
Q3
$21K Buy
31
+17
+121% +$10.7K ﹤0.01% 346
2022
Q2
$8K Hold
14
﹤0.01% 541
2022
Q1
$10K Buy
14
+1
+8% +$633 ﹤0.01% 530
2021
Q4
$8K Hold
13
﹤0.01% 524
2021
Q3
$8K Hold
13
﹤0.01% 521
2021
Q2
$7K Buy
13
+8
+160% +$4.05K ﹤0.01% 465
2021
Q1
$2K Sell
5
-1
-17% -$487 ﹤0.01% 591
2020
Q4
$3K Buy
6
+3
+100% +$1.62K ﹤0.01% 507
2020
Q3
$2K Hold
3
﹤0.01% 526
2020
Q2
$2K Buy
+3
New +$1.7K ﹤0.01% 514

Other funds holding REGN

Financial Management Professionals's REGN Position: Q2 2026 in Review

Financial Management Professionals reduced its Regeneron Pharmaceuticals (REGN) stake by 38% in Q2 2026, selling an estimated $7.49K and leaving 18 shares worth $11.2K. The position accounts for ﹤0.01% of the portfolio, ranked #562.

Financial Management Professionals first reported a position in REGN in Q2 2020 and has held it in 25 quarters since. The position peaked at $114K in Q1 2024. 1,332 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Financial Management Professionals held 18 shares of Regeneron Pharmaceuticals worth $11.2K as of Q2 2026.
  • Financial Management Professionals sold 11 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $7.49K.
  • Regeneron Pharmaceuticals made up ﹤0.01% of Financial Management Professionals's portfolio in Q2 2026, its #562 holding.
  • Financial Management Professionals first reported a position in Regeneron Pharmaceuticals in Q2 2020 and has held it in 25 quarters since.
  • Financial Management Professionals's Regeneron Pharmaceuticals position peaked at $114K in Q1 2024.
  • 1,332 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Financial Management Professionals's 13F filing for Q2 2026, filed 9 Jul 2026.